Feature
G enetic sequencing has revolutionized biology. It all began with the massive Human Genome Project, which sequenced the human genome in less than its initially estimated 15 years. Now, on a nearly daily basis, articles in Nature, Science, and other journals announce the genomic sequencing of another organism-from microbes to invertebrates to plants and vertebrates. Just a few years ago, someone trying to select a genetic marker in a nonhuman organism would look at the human sequence and hope that it yielded the necessary clues. Now there are enough partial and even full genomic sequences of nonhuman organisms that a closer match may be found.
Although much of the genetic sequencing is of model organismsArabidopsis, zebrafish, rats, mice, dogs, chickens-mitochondrial and nuclear DNA sequences, RNA sequences, and protein structures from many other organisms are being filed in databases by researchers whose interest may not be to sequence an organism's entire genome. These researchers may be doing evolutionary, comparative taxonomic, populational, forensic, drug discovery, or many other types of studies.
Adelgisa (Gisella) Caccone, an evolutionary geneticist at the Yale Institute for Biospheric Studies in New Haven, Connecticut, is comparing mitochondrial DNA sequences of giant tortoises with those from Lonesome George, the sole surviving tortoise from the island of Pinta in the Galápagos, to find a genet- 
GenBank
One of the major advantages of many of these genomic databases is that they are free and open. GenBank, probably the most frequently used, contains sequences for nuclear and mitochondrial DNA and is accessible through the National Center for Biotechnology Information (NCBI) Web site, maintained at the National Institutes of Health's National Library of Medicine. But because scientists who use the genetic databases have various needs, researchers who work on different groups of organisms see the databases in different ways and may use different databases. Caccone can rattle off numerous database uses: searching for a mate for Lonesome George, finding homologous regions in genes, managing endangered species, learning the evolutionary history of a species, studying the population biology of vectors of disease, managing harmful species, and studying the biology and cost of invasive species. Caccone's studies and those of her students are very broad, ranging from the genetics of big-leaf mahogany, to the conservation genetics of certain island populations of Galápagos tortoises and marine iguanas, to captive propagation of the Siberian tiger, and even to determining how to control one of the species of mosquitoes that is a vector for malaria.
One of her interests is the biology of invasive species, and Caccone wonders if understanding the genetics of these animals could help control them. She gives a hypothetical example of how a researcher might use GenBank. She points out that the brown tree snake, Boiga irregularis-a species she is not studying-is an invasive species. It moved into Guam in the 1960s and has cost the US government large amounts of money in its attempts to eradicate it. "You use the database as the first entry to find the genome of a species that's related," she explains. But there are no entries in GenBank for any members of the genus Boiga. For most nonmodel species, she says, one could "probably find 12S mitochondrial DNA sequences or some cytochrome B, or some nuclear ribosomal sequences." A researcher's goal in using GenBank would be to locate homologous sequences from several species related to the species of interest."From there," says Caccone, "you can produce an alignment of sequences. There will be some variation. You want to look for conserved regions that are flanking" the gene in question. Using the sequences flanking the gene and the gene sequence, one can then design primers that will specifically attach to a similar region in the DNA of the specimen in question. "It's a comparative approach," Caccone notes. In closely related species, the region will be invariant, meaning there will be few, if any, base differences between the primer sequence and the sequence in the animal in question. "If it doesn't work, you go back to the drawing board," Caccone advises.
Surprising diversity of spiders
Going back to the drawing board is exactly what Samuel Marshall, of the University of Cincinnati, and his colleagues did when their search for a mitochondrial gene-cytochrome oxidase I (COI)-to aid in studying tarantula evolutionary trees turned up a lot of diversity. This gene, which all animals have, evolves fairly rapidly. "We inferred that these things have been diverging for so long, that wasn't a useful gene," at least not in tarantulas, notes Marshall. They switched spider families completely, studying divergence in eastern US wolf spiders of the genus Geolycosa, again using the COI gene, as well as six nuclear DNA genes. These Geolycosa species are burrowing spiders, some of which are turricolous: that is, they build burrows with entrances surrounded by a turret of leaves and other vegetative debris, all tied together with silk. Other Geolycosa are aturricolous, meaning that they do not build turrets around the mouths of their burrows. According to Marshall and his colleagues, turricolous spiders are larger and darker than aturricolous ones, and the two ecomorphs of spiders live in different habitatsturricolous spiders in areas where there is a lot of leaf litter, aturricolous spiders in barren soil. 
Feature
By using GenBank to identify sequences from closely related taxa-as there's nothing there from the species they're studying-and preparing polymerase chain reaction (PCR) probes from these sequences, Marshall and his colleagues have found a surprising story. "We went into this assuming a fairly simple story of the evolutionary diversification of a turret-building clade and a non-turret-building clade. What we got instead was a more complicated pattern indicating that the non-turretbuilding clade had evolved independently five times," says Marshall. The Geolycosa wolf spiders appear to be monophyletic in origin, descending from one ancestral species, but their more recent evolution is complicated by hybridization with an ecologically dominant sister species and rapid and recent formation of species. Furthermore, systematic analyses based on morphological traits do not clearly explain the relationships between the members of the genus.
Marshall and his group plan to continue their work by looking at other members of the genus and members of the subfamily Lycosinae. They also plan to use scanning electron microscopy to identify morphological characters that may better aid in solving the systematics of the genus.
Solving wildlife mysteries
George Amato, director of conservation and science for the Wildlife Conservation Society, Bronx, New York, uses GenBank and, occasionally, the European Molecular Biology Laboratory, or EMBL, databases in "solving a wildlife mystery." He and his colleagues mainly work in wildlife forensics, although most of his data never find their way into a courtroom. Amato often starts with an unknown: hair found in a trap used by researchers in China to catch pandas so they can be fitted with radio collars, a sample from Vermont that may-or may not-be from a mountain lion, or smoked monkey meat confiscated at New York's John F. Kennedy Airport by the US Department of Agriculture (USDA).
Amato will extract DNA from the unknown sample and sequence it. He'll then type the sequence into one of the search modes for GenBank and, he says, "It's the 'eureka' moment. You'll get a list of all of these sequences that are in the database. It will say it matches it 100 percent, 99 percent, 98 percent.... Even if it doesn't match 100 percent, it will give you a series of answers from which it would give you a good idea of what you might compare it to." He adds, "Because of the ease of use of GenBank for this purpose, it's something we can almost train a high school intern to do."
He explains how they discovered the species of some of the monkey meat from a shipment of about 65 smoked monkeys that had come in on a flight from Africa. The meat had been destined "to be sold as a specialty food item in the West African community in New York," he recalls. "You could tell it was a monkey; it had an arm and a hand. You couldn't tell what species it was." Amato explains that identifying the species was essential in determining whether this was a simple violation of USDA regulations, bringing in undeclared meat,"like bringing in prosciutto from Italy," or a more serious violation of federal endangered species laws or international treaties. After sequencing the DNA from samples and running the sequences through GenBank, Amato says, "in one specific case, we got a perfect match. It was a red colobus monkey, which is an endangered species." A second sample came up as a guenon, a member of a group of medium-sized African monkeys. But because this particular species had never been sequenced, there was nothing in the database that perfectly matched this sample.
Amato explains, "With that information, we could try to obtain samples from other species of guenons to try to get a perfect match." Such work would likely add more sequences to the GenBank database. Like Caccone, Amato also uses GenBank to design PCR primers for use on DNA from a species he hasn't previously worked on but that has related species in the databank.
Viruses and their hosts
Some researchers, such as the group studying hepatitis viruses, use both the genetic and proteomic databases. Scientists at the Hepatitis B Foundation in Doylestown, Pennsylvania, are studying the hepatitis B and hepatitis C viruses. These researchers are identifying unique peptides through use of mass spectrophotometry. "We get the spectra of the peptides [that] are totally unknown peptides," says Mohan Philip. "We use the spectra to derive the protein sequence." Ramila Philip notes, "The mass and the spectra information is searched against the protein's amino acid sequence in a protein database, such as PIR, looking for a matching protein using special software." She continues, "The way we use this database is to find the portion of the protein that is being used by the cell" and determine what portion of the protein is recognized by the human immune system. After matching the protein in question with a protein in the protein database, says Ramila Philip, "then we synthesize the peptide and confirm the sequence by mass spectrometry analysis." Pamela Norton of the Drexel Institute for Biotechnology and Virology Research, Drexel University College of Medicine in Doylestown, Pennsylvania, takes this one step further. She's studying DNA sequences of host genes-in rats and other mammals-trying to identify possible functional regions or regulatory sequences that may determine their response to hepatitis B virus infection. "Cross-species comparisons become useful because there is the general observation that functionally important sequences tend to be more strongly conserved when you look across species," she says. Like other research groups, Norton and her colleagues not only download sequencing information; they also upload their sequencing information to GenBank.
One of their projects is to determine

The Eastern US wolf spiders of the genus Geolycosa are burrowing spiders that are monophyletic in origin. The turricolous wolf spiders, such as Geolycosa hubbelli (top left), build elegant turrets around the entrances to their burrows (bottom left). The aturricolous clades, as represented by Geolycosa xera archboldi (top right), which do not build turreted entrances to their burrows (bottom right), appear to
The Institute for Genomic Research (TIGR) in Rockville, Maryland, is one of the largest creators of genomic databases and information that is deposited in databases. "We are a major data provider," says Steven Salzberg, TIGR's senior director of bioinformatics. TIGR's databases include the Comprehensive Microbial Resource, covering all of the completed bacterial genome sequences; Unfinished Microbial Genomes, covering bacterial genomes that have not yet been completed; Pathema, which includes information on a select group of pathogens; databases on wheat, Tetrahymena (a ciliated protozoan), Arabidopsis (a well-studied model plant), rice, potato, parasites, maize, and many others. Salzberg notes that TIGR sequenced the first full genome, that of the pathogenic bacterium Haemophilus influenzae. TIGR not only generates the data; it has also devised mechanisms to, as Salzberg says,"decorate the genome with all sorts of information." This information includes identification of protein-encoding portions of DNA segments, descriptions of proteins and their functions, and gene expression studies that explain how a gene functions under different conditions. TIGR, according to Salzberg, also is specializing in comparative genomic data. Some of this information, however, "would end up being in our publications, not sitting in a database." Such studies include the evolutionary relationships of 15 different strains of Bacillus anthracis, the bacteria that cause anthrax. These strains, notes Salzberg, all diverged recently, but TIGR is working on methods to "identify very fine-scale differences you can use for diagnosis" in infectious bacteria.
Improving resistance and finding new cures
Until the full chicken genome was sequenced (published in the 9 December 2004 issue of Nature), Hans Cheng of the USDA Agricultural Research Service in East Lansing, Michigan, had to content himself with using the human genome sequences and sequences of other organisms, lining them up, and comparing them with the appropriate area of chicken DNA, RNA, or protein. But now, with the full sequence, a gene can be localized to a particular chromosomal region.
Cheng studies genes of resistance to Marek's disease, a viral disease that causes paralysis in chickens. Pharmaceutical companies are using public and private genomic and proteomic databases not only to study pathogens but also to determine the responses of animal models to potential drugs. James R. Brown, manager of bioinformatics discovery and analysis at GlaxoSmithKline's (GSK's) Collegeville, Pennsylvania, facility, originally trained in marine biology. He moved into evolutionary biology, working in Ford Doolittle's lab on archaeal evolution. He now specializes in evolutionary biology of infectious bacteria, and drug discovery in musculoskeletal diseases and oncology. For his group's work,"DNA is a starting point," he says. They then ask a lot of questions: "I would not only include the genomes of the organisms. What kind of expression data is being [generated]? What sort of SNPs or polymorphism data are available? What [are the] pathway interactions?"
In drug discovery research, Brown explains, what's important in interpreting drug studies in model organisms, such as the dog or mouse, is understanding how protein structure is conserved across species lines."There could be some subtle change in the protein between dog and mouse, and this is where the databases could tell us the changes." GSK buys some data and has in-house databases, but it also uses public databases, such as GenBank and ENSEMBL.
Lots of information, but not perfect
Despite the rapid proliferation of genomic, proteomic, RNA, and gene expression data, the extant databases don't hold everything the researchers want.
Quality control is one issue. Although many publications require deposit of sequence information into a databank prior to publication, there are many sequences that have no publications associated with them and are unverified. Says Caccone, "Anyone can submit a sequence to GenBank." There are, she notes, many sequences in GenBank that contain the letter N, which means that the researchers don't know which of the four nucleotide bases-adenine, guanine, thymine, or cytosine-is in that given position. In some cases, there is no association of the sequence with a voucher specimen in a museum. For less common species, there are no data at all.
Mohan Philip much prefers PIR to Swiss-Prot (which has also joined UniProt) and GenBank. "PIR is the best alternate currently available" to GenBank, he says. But, working on viruses, he finds that sometimes there's a surfeit of information-"too many copies of the same protein"-because "the viruses mutate so often." He continues, "There should be some way to filter out close hits." Ramila Philip notes that these databases contain many viral sequences of mutated viruses that are only slightly modified.
Norton's colleague from Drexel's College of Medicine, Anand Mehta, says that proprietary software, which may cost around $8000 or $10,000, is useful to better access the types of data they use."A lot of good, open-source software [for proteomic databases] is not available," Mehta says. "We'd like to see a lot of the engines that search these databases more open in the public domain."
Cheng points out that some of the data are not in genomic databases, but rest in publications that are indexed in PubMed."A lot of the raw data is not being entered in [the databases] because there's no real standardized format for that." However, he's certain that the staff at NCBI is working on that problem.
Amato sees that there are improvements. "All the things they continue to do in these banks to improve the accuracy of the data they accept-requesting it be validated in different ways, and in asking people to report anytime they find a mismatch between a particular gene region for a particular specieswe're all dependent on that." But data banks alone won't solve complex scientific problems. GSK's Brown explains that having databases, even ones sophisticated enough to follow pathways through gene expression and protein function, is not enough. "The other 50 percent is someone who knows the area." The bottom line, he explains, is that we need knowledge of the biology, too.
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